Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Creutzfeldt–Jakob disease in the Republic of Sakha (Yakutia)

Full Text:


Creutzfeldt–Jakob disease (CJD) is a rare neurodegenerative disease caused by the accumulation of the pathological isoform of prion protein. The classic clinical presentation of CJD is characterized by rapidly progressive dementia, ataxia, myoclonus, and akinetic mutism at the terminal stage of the disease. Of the instrumental techniques, brain magnetic resonance imaging plays a leading role in clinical practice. The authors followed up 4 patients with probable CJD in the Republic of Sakha (Yakutia) in 2014 to 2019. All the patients had approximately the same age (50–60 years) at disease onset and onset with non-specific cerebral symptoms. However, the subsequent development of rapidly progressive dementia and other characteristic features might suggest CJD. The patients were found to have characteristic neuroimaging signs as hyperintensity of the caudate nuclei and pulvinars in the fluid-attenuated inversion recovery (FLAIR) and diffusion weighted imaging (DWI) modes to form the typical signal of hockey sticks, as well as hyperintensity of the gray matter in the DWI mode (the symptom of the «Venus necklace»). In 3 patients, the disease ended fatally within a year of its onset. The fourth patient with a disease duration of 6 months is being supervised at home. The authors reason that the diagnosis of CJD is now insufficient due to the similarity of its clinical symptoms at the onset with other disorders, including cerebrovascular and neurodegenerative diseases.

About the Authors

T. E. Popova
Yakutsk Research Center for Complex Medical Problems
Russian Federation
4, Sergelyakhskoe Shosse, Yakutsk 677000, Russia

A. A. Tappakhov
Yakutsk Research Center for Complex Medical Problems; M.K. Ammosov North-Eastern Federal University
Russian Federation
4, Sergelyakhskoe Shosse, Yakutsk 677000, Russia

58, Belinsky St., Yakutsk 677000, Russia

T. K. Davydova
Yakutsk Research Center for Complex Medical Problems
Russian Federation
4, Sergelyakhskoe Shosse, Yakutsk 677000, Russia

T. Ya. Nikolaeva
M.K. Ammosov North-Eastern Federal University
Russian Federation
58, Belinsky St., Yakutsk 677000, Russia

Yu. I. Khabarova
Yakutsk Research Center for Complex Medical Problems
Russian Federation
4, Sergelyakhskoe Shosse, Yakutsk 677000, Russia

M. A. Varlamova
Yakutsk Research Center for Complex Medical Problems
Russian Federation
4, Sergelyakhskoe Shosse, Yakutsk 677000, Russia

L. T. Okoneshinova
Center for Emergency Medical Care, Republican Hospital Two
Russian Federation
83A, Petr Alekseev St., Yakutsk 677000, Russia


1. Shnaider NA. Creutzfeldt-Jakob disease: a new look at the old problem (history of study, etiology and pathogenesis). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;113(4): 72-9. (in Russ.)].

2. Jacobs DA, Lesser RL, Mourelatos Z, et al. The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings. J Neuroophthalmol. 2001;21(2):99-102. doi: 10.1097/00041327-200106000-00008.

3. Uttley L, Carroll C, Wong R, et al. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020;20(1):e2-e10. doi: 10.1016/S1473-3099(19)30615-2.

4. Creutzfeldt-Jakob Disease International Surveillance Network. CJD surveillance data 1993–2018. 2018.

5. Rabinovici GD, Wang PN, Levin J, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006 Jan 24;66(2):286-7. doi: 10.1212/01.wnl.0000196440.00297.67.

6. Manix M, Kalakoti P, Henri M, et al. Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus. 2015;39(5):E2. doi: 10.3171/2015.8.FOCUS15328.

7. Parchi P, De Boni L, Saverioni D, et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol. 2012 Oct;124(4):517-29. doi: 10.1007/s00401-012-1002-8.

8. Fragoso DC, Goncalves Filho AL, Pacheco FT, et al. Imaging of Creutzfeldt-Jakob disease: imaging patterns and their differential diagnosis. Radiographics. 2017;37(1):234-257. doi: 10.1148/rg.2017160075.

9. Hirst CL. Sporadic Creutzfeldt-Jakob disease presenting as a stroke mimic590. Br J Hosp Med (Lond). 2011;72(10):590-591. doi: 10.12968/hmed.2011.72.10.590.

10. Hanumanthu R, Alchaki A, Nyaboga A, et al. An unusual case of sporadic CreutzfeldJacob disease presenting as acute neuropathy. Mov Disord. 2017;32:563-4.

11. Karatas H, Dericioglu N, Kursun O, et al. Creutzfeldt-Jakob disease presenting as hyperparathyroidism and generalized tonic status epilepticus. Clin EEG Neurosci. 2007 Oct; 38(4):203-6. doi: 10.1177/155005940703800404.

12. Pachalska M, Kurzbauer H, ForminskaKapuscik M, et al. Atypical features of dementia in a patient with Creutzfeldt-Jakob disease. Med Sci Monit. 2007 Jan;13(1):CS9-19. Epub 2006 Dec 18.

13. Litzroth A, Cras P, De Vil B, Quoilin S. Overview and evaluation of 15 years of Creutzfeldt-Jakob disease surveillance in Belgium, 1998–2012. BMC Neurol. 2015 Dec 2;15:250. doi: 10.1186/s12883-015-0507-x.

14. Mahboob HB, Kaokaf KH, Gonda JM. Creutzfeldt-Jakob Disease Presenting as Expressive Aphasia and Nonconvulsive Status Epilepticus. Case Rep Crit Care. 2018:5053175. doi: 10.1155/2018/5053175.

15. Ali R, Baborie A, Larner AJ, et al. Psychiatric presentation of sporadic Creutzfeldt-Jakob disease: a challenge to current diagnostic criteria. J Neuropsychiatry Clin Neurosci. 2013;25(4):335-8. doi: 10.1176/appi.neuropsych.13020025.

16. Rodriguez-Porcel F, Ciarlariello VB, Dwivedi AK, et al. Movement Disorders in Prionopathies: A Systematic Review. Tremor Other Hyperkinet Mov (NY). 2019;9. doi: 10.7916/tohm.v0.712. eCollection 2019.

17. Sakuma T, Watanabe S, Ouchi A, et al. Three Cases of Creutzfeldt-Jakob Disease with Visual Disturbances as Initial Manifestation. Case Rep Ophthalmol. 2019 Oct 23;10(3): 349-356. doi: 10.1159/000503274. eCollection 2019 Sep-Dec.

18. Rudge P, Jaunmuktane Z, Adlard P, et al. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain. 2015;138(11): 3386–3399. doi: 10.1093/brain/awv235.

19. Thompson A, MacKay A, Rudge P, et al. Behavioral and psychiatric symptoms in prion disease. Am J Psychiatry. 2014;171(3):265-274. doi: 10.1176/appi.ajp.2013.12111460.

20. Peresedova AV, Stoida NI, Gnezditskii VV, et al. Sporadic Creutzfeldt-Jakob disease: a clinical observation. Annaly klinicheskoi i eksperimental'noi nevrologii. 2011;5(4): 52-6. (In Russ.)].

21. Kurushina OV, Miroshnikova VV, Krivonozhkina PS. A case of familial Creutzfeldt-Jakob disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018;118(9): 94-7. (In Russ.)].

22. Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76(20):1711-1719. doi: 10.1212/WNL.0b013e31821a4439.

23. Zerr I, Kallenberg K, Summers D, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(10): 2659-2668. doi: 10.1093/brain/awp191.

24. Geschwind MD. Prion diseases. Continuum (Minneap Minn). 2015 Dec;21(6 Neuroinfectious Disease):1612-38. doi: 10.1212/CON.0000000000000251.

25. McGuire LI, Peden AH, Orru CD, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic CreutzfeldtJakob disease. Ann Neurol. 2012;72(2):278-285. doi: 10.1002/ana.23589.

26. Satoh K, Fuse T, Nonaka T, et al. Postmortem Quantitative Analysis of Prion Seeding Activity in the Digestive System. Molecules. 2019 Dec 16;24(24). pii: E4601. doi: 10.3390/molecules24244601.

27. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet. 2001 Jul 21;358(9277):171-80. doi: 10.1016/s0140-6736(01)05403-4.

28. Klug GM, Wand H, Boyd A, et al. Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster. Brain. 2009 Feb;132(Pt 2):493-501. doi: 10.1093/brain/awn303. Epub 2008 Nov 28.

29. Klug GM, Wand H, Simpson M, et al. Intensity of human prion disease surveillance predicts observed disease incidence. J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1372-7. doi: 10.1136/jnnp-2012-304820. Epub 2013 Aug 21.

For citation:

Popova T.E., Tappakhov A.A., Davydova T.K., Nikolaeva T.Y., Khabarova Y.I., Varlamova M.A., Okoneshinova L.T. Creutzfeldt–Jakob disease in the Republic of Sakha (Yakutia). Neurology, Neuropsychiatry, Psychosomatics. 2020;12(2):86-91. (In Russ.)

Views: 51

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)